Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of Mounjaro (tirzepatide), and it tends to be at its worst in the first few weeks of treatment. It happens because tirzepatide slows the rate at which your stomach empties, which is part of how it reduces appetite — but that same mechanism can leave food sitting in your stomach longer than it used to, triggering queasiness. For many people it eases considerably once the body adjusts to the starting dose. Mounjaro is a prescription-only medicine, and a prescriber reviews whether it is suitable for you before treatment begins, including a conversation about what to expect in those early weeks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that are naturally involved in regulating appetite and blood sugar. One of the things those hormones do is slow gastric emptying: the speed at which food moves from your stomach into the small intestine. In everyday terms, a meal that would normally pass through in two hours might linger for three or four. That prolonged fullness is genuinely useful for weight management, but when you first start treatment your body hasn't adapted to the new pace yet.
The result for most people is a queasy, heavy sensation that tends to appear a few hours after eating, particularly after larger meals or fatty foods. Some describe it as persistent low-grade nausea; others get a sharper wave of sickness that passes quickly. Both responses are connected to the same mechanism. The NHS medicine information for tirzepatide lists nausea as a very common side effect, so if you're feeling it, you're firmly in the majority of people who start this medicine.
If you want a fuller picture of the broader side-effect profile, the Mounjaro side effects overview covers the complete list, including which ones are common and which are rare.
There's a reason Mounjaro's prescribing schedule begins at 2.5mg: that first dose exists specifically to let your digestive system acclimatise before the therapeutic doses arrive. Most people find the 2.5mg period manageable precisely because the gastric effect is relatively mild. Nausea often picks up again when the dose steps up, because each increase pushes the gastric-emptying effect further before the body has settled at the new level.
This pattern is worth knowing in advance. It doesn't mean the treatment isn't working, or that something is wrong, it usually means you're right on schedule. The discomfort is typically sharpest in the first few days after a dose change and then softens. If you're currently navigating nausea after a recent increase, the detailed guide on managing Mounjaro nausea has practical strategies worth reading alongside your Patient Information Leaflet.
A few factors can make nausea worse regardless of dose: eating large portions, meals high in fat or very rich foods, eating too quickly, lying down soon after eating, and drinking alcohol. These aren't absolute rules, but most people find that trimming portion size and slowing down at mealtimes makes a noticeable difference in the first weeks. You can also read about what helps with Mounjaro nausea for more evidence-based options to discuss with your prescriber.
Nausea rarely travels alone. Because tirzepatide affects the whole digestive process, it often brings other gastrointestinal symptoms with it, most commonly constipation, loose stools, indigestion, and burping. These are all listed as very common effects in the Mounjaro SmPC on the electronic medicines compendium (eMC). The causes of diarrhoea on Mounjaro and the curious phenomenon of eggy burps on Mounjaro each have their own dedicated pages if those are troubling you too.
That combination of symptoms is inconvenient, but they tend to move in the same direction over time: settling as the body adapts. Staying well hydrated matters more than people expect. When nausea is accompanied by repeated vomiting or diarrhoea, fluid loss can accumulate quickly, so sipping water consistently throughout the day is worth making a habit from day one. If you're unsure whether what you're experiencing is typical, our prescribers go through exactly this at consultation, take a look at the reasons Mounjaro causes nausea page for a deeper mechanistic explanation.
Nausea that is mild-to-moderate, comes and goes, and is clearly tied to eating or a recent dose change is expected and generally not a concern. There are situations, however, where you should stop and get medical advice promptly rather than waiting it out.
The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known but infrequent side effect of GLP-1 medicines, including tirzepatide. The key warning sign is severe stomach pain that doesn't ease and may spread to the back, sometimes with vomiting. That is different from ordinary nausea and needs urgent medical assessment. Call 111 or go to A&E if it happens.
Other situations that warrant a call to your prescriber or 111 rather than waiting: vomiting so persistent that you cannot keep fluids down for more than 24 hours; signs of dehydration such as very dark urine, dizziness on standing, or a dry mouth that won't resolve with drinking; and any symptoms that feel sudden or serious in a way that doesn't match the gradual, adjusting pattern described above. You can also report concerns directly to the MHRA using the Yellow Card scheme, patient reports genuinely shape how drug safety is monitored in the UK.
If you'd like to understand more about Mounjaro generally before or during treatment, the Mounjaro treatment page covers the full picture. Our prescribers discuss side effects, your health history and what to expect as a standard part of every consultation, that conversation is included at no extra cost. Start your free consultation if you'd like to explore whether Mounjaro is clinically suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.